|
91 |
Breastfeeding in HIV-Positive Women
Enthalten in Pediatric drugs Bd. 12, 22.8.2012, Nr. 1, date:2.2010: 1-9
|
|
|
|
92 |
Brentuximab Vedotin
Enthalten in Drugs in R & D Bd. 11, 27.11.2012, Nr. 1, date:3.2011: 85-95
|
|
|
|
93 |
Budget impact analysis of switching to darunavir/ritonavir monotherapy for HIV-infected people in Spain
Enthalten in Applied health economics and health policy Bd. 10, 6.8.2012, Nr. 2, date:3.2012: 139-141
|
|
|
|
94 |
Burden of a Multiple Sclerosis Relapse
Enthalten in The Patient Bd. 5, 24.8.2012, Nr. 1, date:3.2012: 57-69
|
|
|
|
95 |
Cabazitaxel
Enthalten in Drugs Bd. 71, 15.10.2012, Nr. 10, date:7.2011: 1251-1258
|
|
|
|
96 |
Calcineurin Inhibitors in Pediatric Atopic Dermatitis
Enthalten in American journal of clinical dermatology Bd. 12, 10.9.2012, Nr. 1, date:2.2011: 15-24
|
|
|
|
97 |
Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin Degludec
Enthalten in Drugs Bd. 72, 26.12.2012, Nr. 18, date:12.2012: 2319-2325
|
|
|
|
98 |
Can Neuromuscular Fatigue Explain Running Strategies and Performance in Ultra-Marathons?
Enthalten in Sports medicine Bd. 41, 7.10.2012, Nr. 6, date:6.2011: 489-506
|
|
|
|
99 |
Can Social Media Benefit Drug Safety?
Enthalten in Drug safety Bd. 34, 20.11.2012, Nr. 9, date:9.2011: 793
|
|
|
|
100 |
Can’t Get No Satisfaction? Will Pay for Performance Help?
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 2, date:2.2010: 93-102
|
|
Administration
